MedPath

Volume Responsiveness Assesment After Propofol.

Completed
Conditions
Circulatory Failure
Fluid Volume Disorder
Critical Illness
Interventions
Registration Number
NCT03917446
Lead Sponsor
Medical University of Gdansk
Brief Summary

Patients in ICU who suffer from circulatory insufficiency, regardless the cause that require invasive hemodynamic monitoring. The aim of the study is to correlate stroke volume variation which predicts fluid responsiveness with change of the blood pressure after intravenous admission of propofol. This test could become a surrogate of stroke volume variation in patients with contraindications to minimally invasive hemodynamic monitoring.

Detailed Description

This prospective, observational study was conducted after approval of the Independent Bioethics Commitee at Medical University of Gdańsk (numer zgody) and registered in ClinicalTrials.gov. Mechanically ventilated patients of intensive care unit who routinely recieved haemodynamic monitoring with PiCCO™ (Getinge AB, Sweden) technology using Philips IntelliVue PiCCO-Module (Philips Healthcare, Amsterdam, Netherlands), were enrolled. Patients were sedated with midazolam infusion at 0,15 to 0,6 mg kg-1 h-1 . Before the trial in each patient, heart rate (HR) invasive (IBP) and non - invasive blood pressure, (NIBP) infusion rate of catecholamines and non adrenergic vasopressors was recorded and PiCCO device was callibrated by transpulmonary thermodilution with 20 ml of cold saline. Global end diastolic volume (GEDV), intrathoracic blood volume (ITBV) and stroke volume variation (SVV) were calculated and recorded. For effective ventilation with increased tidal volume of 8 ml kg-1 of Predicted Body Weight, each patient recieved propofol bolus of 0,25 mg kg-1, 0,5 mg kg-1 and 1,0 mg kg-1 consecutively. Higher doses were used at good tolerance of the lower ones. After each bolus systolic and diastolic invasive blood pressure, heart rate (HR), continuous cardiac output (CCO), continuous cardiac index (CCI), stroke volume index (SI), stroke volume variantion (SVV), and left ventricular contractility index (dPmax) were recorded every fifteen seconds for ten minutes. The absolute and realtive change in blood pressure, compared to the values of blood pressure before the drug administration, were correlated with SVV. Time interval between each examination ranged from 4 to 48 hours.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria

ICU patient Haemodynamically instable Mechanically ventilated

Exclusion Criteria

Simultaneous propofol infusion Contraindications for propofol Atrial fibrillation Valvular malfunction Aortic stenosis Aortic aneurysm

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
EuvolaemicPropofol bolusPatients with stroke volume variation less than 8%
HypovolaemicPropofol bolusPatients with stroke volume variation greater than 13%
Primary Outcome Measures
NameTimeMethod
Maximum left ventricular contractility (dPmax)10 minutes

Change in dPmax values after propofol bolus.

Blood pressure10 minutes

Change in blood pressure values after propofol bolus.

Heart rate10 minutes

Change in heart rate values after propofol bolus.

Cardiac output10 minutes

Change in cardiac output values after propofol bolus.

Cardiac index10 minutes

Change in cardiac index values after propofol bolus.

Stroke volume10 minutes

Change in stroke volume values after propofol bolus.

Stroke index10 minutes

Change in stroke index values after propofol bolus.

Stroke volume variation10 minutes

Change in stroke volume variation values after propofol bolus.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Medical University of Gdańsk - Departament of Anesthesiology and Intensive Care

🇵🇱

Gdańsk, Poland

© Copyright 2025. All Rights Reserved by MedPath